The licensing agreement reached between Johnson & Johnson (J&J) and the Stop TB Partnership on Thursday to allow the generic production of the tuberculosis drug, bedaquiline, is simply a “stop-gap” measure that applies to a limited number of countries, according to Médecins Sans Frontières (MSF). At least nine countries in the Eastern Europe and Central […] Continue reading ->
A tuberculosis (TB) vaccine candidate that has shown modest efficacy rates received a $550 million boost from the Bill and Melinda Gates Foundation (BMGF) and Wellcome Trust, which announced on Tuesday that they will cover its Phase 3 clinical trials. The candidate vaccine, M72, showed modest 54% efficacy in preventing the development of symptomatic TB […] Continue reading ->
The call and response of “Yes we can, end TB” at the Multi-Stakeholder Hearing (MSH) on tuberculosis (TB) made one thing clear — the voices of the community will be heard. With negotiations of the UN Political Declaration now underway, what does the TB community expect to see? Members of the global TB community, including […] Continue reading ->
The United Nations (UN) is hosting three multi-stakeholder meetings in New York on Monday and Tuesday on tuberculosis, pandemic prevention, preparedness and response (PPPR) and universal health coverage (UHC). They are aimed at getting the views of non-state actors in preparation for UN High-Level meetings in September, starting with pandemic preparedness on 20 September, followed […] Continue reading ->